OUTCOME OF CONTINUATION OF BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA

被引：0
|
作者：
Chamberlain, Marc C. [1 ]
机构：
[1] Univ Washington, Fred Hutchinson Res Canc Ctr, Seattle, WA 98195 USA
来源：
NEURO-ONCOLOGY | 2011年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [1] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    Reardon, D. A.
    Herndon, J. E., II
    Peters, K. B.
    Desjardins, A.
    Coan, A.
    Lou, E.
    Sumrall, A. L.
    Turner, S.
    Lipp, E. S.
    Sathornsumetee, S.
    Rich, J. N.
    Sampson, J. H.
    Friedman, A. H.
    Boulton, S. T.
    Bigner, D. D.
    Friedman, H. S.
    Vredenburgh, J. J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1481 - 1487
  • [2] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    D A Reardon
    J E Herndon
    K B Peters
    A Desjardins
    A Coan
    E Lou
    A L Sumrall
    S Turner
    E S Lipp
    S Sathornsumetee
    J N Rich
    J H Sampson
    A H Friedman
    S T Boulton
    D D Bigner
    H S Friedman
    J J Vredenburgh
    British Journal of Cancer, 2012, 107 : 1481 - 1487
  • [3] Bevacizumab in recurrent glioblastoma
    Martinez, Nina L.
    Glass, Jon
    Shi, Wenyin
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S162 - S163
  • [4] Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma
    Duerinck, Johnny
    Clement, Paul M.
    Bouttens, Frank
    Andre, Chantal
    Neyns, Bart
    Staelens, Yves
    Van Fraeyenhove, Frank
    Baurain, Jean-Francois
    Luce, Sylvie
    D'hondt, Lionel
    Joosens, Eric
    Specenier, Pol
    Verschaeve, Vincent
    Filleul, Bertrand
    Vroman, Philippe
    Stragier, Barbara
    Rogiers, Anne
    JOURNAL OF NEUROLOGY, 2015, 262 (03) : 742 - 751
  • [5] Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma
    Johnny Duerinck
    Paul M. Clement
    Frank Bouttens
    Chantal Andre
    Bart Neyns
    Yves Staelens
    Frank Van Fraeyenhove
    Jean-Francois Baurain
    Sylvie Luce
    Lionel D’hondt
    Eric Joosens
    Pol Specenier
    Vincent Verschaeve
    Bertrand Filleul
    Philippe Vroman
    Barbara Stragier
    Anne Rogiers
    Journal of Neurology, 2015, 262 : 742 - 751
  • [6] Bevacizumab in recurrent glioblastoma multiforme
    Tayah, Tania
    Ashrafieh
    Chahine, Georges Y.
    Kamar, Francois G.
    NEUROLOGY, 2008, 70 (11) : A296 - A297
  • [7] Bevacizumab for the Treatment of Recurrent Glioblastoma
    Chamberlain, Marc C.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 117 - 129
  • [8] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Hamza, Mohamed A.
    Mandel, Jacob J.
    Conrad, Charles A.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    DeGroot, John F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (01) : 135 - 140
  • [9] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Mohamed A. Hamza
    Jacob J. Mandel
    Charles A. Conrad
    Mark R. Gilbert
    W. K. Alfred Yung
    Vinay K. Puduvalli
    John F. DeGroot
    Journal of Neuro-Oncology, 2014, 119 : 135 - 140
  • [10] Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
    Johansen, Maria Dinche
    Urup, Thomas
    Holst, Camilla Bjornbak
    Christensen, Ib Jarle
    Grunnet, Kirsten
    Lassen, Ulrik
    Friis, Soren
    Poulsen, Hans Skovgaard
    CANCER INVESTIGATION, 2018, 36 (9-10) : 512 - 519
12345